Literature DB >> 11374420

Guillain-Barre syndrome in organ and bone marrow transplant patients.

K R Bulsara1, P W Baron, J E Tuttle-Newhall, P A Clavien, J Morgenlander.   

Abstract

BACKGROUND: Guillain-Barre Syndrome (GBS) is believed to be caused by autoimmune mechanisms that are predominantly T-cell mediated. We report GBS in organ transplant patients and bone marrow transplant patients, both of whom have iatrogenically suppressed T-cell function.
METHODS: We reviewed the Duke University Medical Center database from 1989-1999 for all patients who met the criteria for GBS. There were a total of 212 patients. Of these patients, two had undergone organ transplantation and two had undergone autologous bone marrow transplantation.
RESULTS: Our report supports the notion that the humoral immune system is involved in the pathogenesis of GBS. Contrary to previous reports, however, functional recovery can occur without return of T-cell function.
CONCLUSIONS: This suggests that in organ transplant patients, GBS may be humorally mediated and, even more importantly, responds well to treatment.

Entities:  

Mesh:

Year:  2001        PMID: 11374420     DOI: 10.1097/00007890-200104270-00026

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  13 in total

1.  Update on paraneoplastic neurologic disorders.

Authors:  Myrna R Rosenfeld; Josep Dalmau
Journal:  Oncologist       Date:  2010-05-17

2.  Anti-phospholipid antibodies in serum from patients with Guillain-Barré syndrome.

Authors:  G Nakos; E Tziakou; L Maneta-Peyret; C Nassis; M E Lekka
Journal:  Intensive Care Med       Date:  2005-07-26       Impact factor: 17.440

3.  Guillain-barré syndrome mimicking nerve injury after total hip arthroplasty.

Authors:  Benton E Heyworth; Peter D Fabricant; Mark M Pizzurro; Burak Beksac; Eduardo A Salvati
Journal:  HSS J       Date:  2011-07-13

4.  Neurological Complications after Renal Transplantation: A Retrospective Clinical Study.

Authors:  Nilgün Cengiz; Zelal Adibelli; Yarkın Kamil Yakupoğlu; Hande Türker
Journal:  Noro Psikiyatr Ars       Date:  2015-12-01       Impact factor: 1.339

Review 5.  Transient immunosuppression: a bridge between infection and the atypical autoimmunity of Guillain-Barré syndrome?

Authors:  I Steiner; G Rosenberg; I Wirguin
Journal:  Clin Exp Immunol       Date:  2010-10       Impact factor: 4.330

6.  Guillain Barré syndrome precipitated by the use of antilymphocyte globulin in the treatment of severe aplastic anaemia.

Authors:  B Kaya; C E Davies; H E Oakervee; N C Silver; J Gawler; J D Cavenagh
Journal:  J Clin Pathol       Date:  2005-09       Impact factor: 3.411

7.  Cytomegalovirus disease with Guillain-Barré syndrome in a cadaver renal allograft recipient: cause or coincidence.

Authors:  Sai Ram R Keithi-Reddy; Rajasekhara M Chakravarthi; Shaista M Hussaini; Rohini R Venkatapuram; J M K Murthy
Journal:  Int Urol Nephrol       Date:  2007-04-21       Impact factor: 2.370

8.  Central and peripheral nervous system immune mediated demyelinating disease after allogeneic hemopoietic stem cell transplantation for hematologic disease.

Authors:  Anna Maria Delios; Marc Rosenblum; Ann A Jakubowski; Lisa M DeAngelis
Journal:  J Neurooncol       Date:  2012-08-23       Impact factor: 4.130

9.  Muscle cramps and neuropathies in patients with allogeneic hematopoietic stem cell transplantation and graft-versus-host disease.

Authors:  Peter D Kraus; Daniel Wolff; Oliver Grauer; Klemens Angstwurm; Sven Jarius; Klaus P Wandinger; Ernst Holler; Wilhelm Schulte-Mattler; Ingo Kleiter
Journal:  PLoS One       Date:  2012-09-17       Impact factor: 3.240

10.  Acute demyelinating polyneuropathy after lung transplantation: guillain-barré syndrome or tacrolimus toxicity?

Authors:  Nirmal S Sharma; Keith M Wille; Charles W Hoopes; Enrique Diaz-Guzman
Journal:  Case Rep Transplant       Date:  2014-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.